(Q42804166)

English

Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II

scientific article published on February 20, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311390

11 September 2022

0 references

1 reference

based on heuristic

inferred from title

myeloid leukemia

1 reference

based on heuristic

inferred from title

structural biology

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

author name string

M. S. Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311390

11 September 2022

J. C. Wang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311390

11 September 2022

M. Beran

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1311390

11 September 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

7 November 2017

20 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1311390

11 September 2022

full work available at URL

https://api.elsevier.com/content/article/PII:002228369290245F?httpAccept=text/xml

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

https://api.elsevier.com/content/article/PII:002228369290245F?httpAccept=text/plain

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Journal of Molecular Biology

1 reference

Europe PubMed Central

7 November 2017

223

1 reference

Europe PubMed Central

7 November 2017

4

1 reference

Europe PubMed Central

7 November 2017

837-843

1 reference

Europe PubMed Central

7 November 2017

describes a project that uses

0 references

0 references

DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy

1

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).

2

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition

5

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

6

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the c

8

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy

10

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

The 52-protein subunit of T4 DNA topoisomerase is homologous to the gyrA-protein of gyrase

11

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39.

12

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA topoisomerase poisons as antitumor drugs

13

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Mechanistic aspects of DNA topoisomerases.

14

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region

15

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA topoisomerases as targets for cancer therapy

17

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

19

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase

20

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA sequence analysis with a modified bacteriophage T7 DNA polymerase

21

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites

22

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

23

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

24

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA topoisomerases

27

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA Modification and Cancer

28

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II.

30

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli

31

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

DNA topoisomerase II as a target of antineoplastic drug therapy

32

1 reference

10.1016/0022-2836(92)90245-F

https://api.crossref.org/works/10.1016/0022-2836(92)90245-F

1 December 2023

Identifiers

10.1016/0022-2836(92)90245-F

1 reference

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42804166&oldid=2021659156"